Skip to main content
. 2007 Summer;12(2):91–96.

TABLE 1.

Baseline demographic and hemodynamic characteristics of the patients

Characteristic Atorvastatin (n=25) Atorvastatin + fenofibrate (n=25) Simvastatin (n=27) Simvastatin + fenofibrate (n=25)
Age, years* 56.76±9.4 56.44±9.95 58.44±11.4 58.35±11.35
Sex, %
 Female 4 12 7.4 20
 Male 96 88 92.6 80
Body mass index, kg/m2* 25.79±3.5 23.62±1.95 25.3±3.9 25.44±4.25
Smokers, % 12 20 14.81 8
Tobacco chewers, % 12 12 7.4 4
Diabetics, % 24 36 29.62 48
Hypertensives, % 28 28 51.85 40
Hemoglobin, g/L* 126.1±16.0 121.7±17.5 131.6±17.6 130.7±16.5
Urea (mmol/L)* 10.9±6.74 9.57±4.26 9.61±4.71 9.60±4.71
Creatinine (μmol/L)* 108.73±44.2 113.15±97.24 97.24±27.4 97.24±27.4
Random glucose (mmol/L)* 7.17±2.16 8.07±3.6 7.58±3.16 7.56±3.11
SBP, mmHg* 126.54±16.05 129.52±24.25 128.22±22.47 128.84±22.8
DBP, mmHg* 81.29±8.75 78.35±9.00 80.55±11.31 80.96±11.55
Pulse, beats/min* 77.09±15.4 80.55±10.9 75.02±15.46 75.29±15.65
LVEF, %* 46.8±12.35 50.94±16.25 52.44±12.79 52.51±5.76
Number of affected vessels, %
 One 68 56 55.55 44
 Two 28 28 29.62 36
 Three 4 16 14.81 20
*

Data expressed as mean ± SD. DBP Diastolic blood pressure; LVEF Left ventricular ejection fraction; SBP Systolic blood pressure